CIB0.DE vs. GN0M.DE
CIB0.DE (VanEck Bionic Engineering UCITS ETF A) and GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds - CIB0.DE tracks the MVIS Global Bionic Healthcare ESG while GN0M.DE tracks the Solactive Genomics. Both are passively managed. Over the past 3 years, CIB0.DE returned -8.20%/yr vs -1.90%/yr for GN0M.DE. A 0.52 correlation means they provide meaningful diversification when combined. CIB0.DE charges 0.55%/yr vs 0.50%/yr for GN0M.DE.
Performance
CIB0.DE vs. GN0M.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CIB0.DE achieves a -14.18% return, which is significantly lower than GN0M.DE's 12.99% return.
CIB0.DE
- 1D
- 3.05%
- 1M
- 1.36%
- YTD
- -14.18%
- 6M
- -17.46%
- 1Y
- -15.36%
- 3Y*
- -8.20%
- 5Y*
- —
- 10Y*
- —
GN0M.DE
- 1D
- 5.61%
- 1M
- 11.50%
- YTD
- 12.99%
- 6M
- 9.82%
- 1Y
- 55.73%
- 3Y*
- -1.90%
- 5Y*
- —
- 10Y*
- —
CIB0.DE vs. GN0M.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CIB0.DE VanEck Bionic Engineering UCITS ETF A | -14.18% | -10.00% | 5.16% | 2.09% | -1.65% |
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 12.99% | 5.67% | -12.40% | -9.04% | -4.63% |
Correlation
The correlation between CIB0.DE and GN0M.DE is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Dec 8, 2022 | 0.52 |
The correlation between CIB0.DE and GN0M.DE has been stable across timeframes, ranging from 0.45 to 0.52 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CIB0.DE vs. GN0M.DE — Risk / Return Rank
CIB0.DE
GN0M.DE
CIB0.DE vs. GN0M.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CIB0.DE | GN0M.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.89 | ||
| Sortino ratioReturn per unit of downside risk | -4.02 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.33 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.65 | 3.32 | -3.97 |
| Martin ratioReturn relative to average drawdown | -1.67 | 8.35 | -10.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CIB0.DE | GN0M.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.89 | 2.00 | -2.89 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | -0.34 | +0.03 |
Drawdowns
CIB0.DE vs. GN0M.DE - Drawdown Comparison
The maximum CIB0.DE drawdown since its inception was -32.60%, smaller than the maximum GN0M.DE drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for CIB0.DE and GN0M.DE.
Loading charts...
Drawdown Indicators
| CIB0.DE | GN0M.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.60% | -67.19% | +34.59% |
Max Drawdown (1Y)Largest decline over 1 year | -23.47% | -16.68% | -6.79% |
Max Drawdown (3Y)Largest decline over 3 years | -32.60% | -48.19% | +15.59% |
Current DrawdownCurrent decline from peak | -28.26% | -41.03% | +12.77% |
Average DrawdownAverage peak-to-trough decline | -10.72% | -43.13% | +32.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.08% | 6.65% | +2.43% |
Volatility
CIB0.DE vs. GN0M.DE - Volatility Comparison
The current volatility for VanEck Bionic Engineering UCITS ETF A (CIB0.DE) is 6.42%, while Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a volatility of 8.15%. This indicates that CIB0.DE experiences smaller price fluctuations and is considered to be less risky than GN0M.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CIB0.DE | GN0M.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.42% | 8.15% | -1.73% |
Volatility (6M)Calculated over the trailing 6-month period | 12.62% | 19.69% | -7.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.03% | 27.68% | -10.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.95% | 31.49% | -13.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.95% | 31.49% | -13.54% |
CIB0.DE vs. GN0M.DE - Expense Ratio Comparison
CIB0.DE has a 0.55% expense ratio, which is higher than GN0M.DE's 0.50% expense ratio.
Dividends
CIB0.DE vs. GN0M.DE - Dividend Comparison
Neither CIB0.DE nor GN0M.DE has paid dividends to shareholders.
Frequently Asked Questions
CIB0.DE and GN0M.DE have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GN0M.DE is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GN0M.DE is cheaper with a 0.50% expense ratio, compared with 0.55% for CIB0.DE.
CIB0.DE tracks MVIS Global Bionic Healthcare ESG, while GN0M.DE tracks Solactive Genomics. They also come from different issuers: VanEck and Global X. Their fees differ too: 0.55% for CIB0.DE and 0.50% for GN0M.DE.
Find the right allocation for CIB0.DE and GN0M.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer